静脉注射蒂欧本与埃托米达对重度抑郁症患者修饰性电疗法 (MECT) 的影响
Balapriya Boopathy1, Suneeth P Lazarus1, Dilip Chandar1
1Anesthesiology, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, IND.
Cureus
|December 12, 2025
概括
埃托米达在接受改性电疗法 (MECT) 的患者中提供了较长的发作持续时间,而不是提欧. 这表明,埃托米达可能为严重抑郁症治疗提供更好的质量.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 麻醉学 麻醉学
背景情况:
- 电疗法 (ECT) 是对抗药性重度抑郁症的重要治疗方法.
- 为ECT优化诱导剂仍然是研究的一个关键领域.
- 改性电疗法 (MECT) 需要仔细选择麻醉剂.
研究的目的:
- 为了比较etomidate与thiopentone在MECT中的诱导剂的疗效.
- 评估这些药物对主要抑郁症患者发作持续时间和质量的影响.
主要方法:
- 这是一项双盲随机研究,涉及40名患有严重抑郁症的患者.
- 患者接受了静脉注射埃托米达 (0.2毫克/公斤) 或静脉注射蒂欧本 (3毫克/公斤).
- 使用袖口方法测量了发作持续时间后诱导和肌肉放松.
主要成果:
- 埃托米达特组 (A组) 的平均发作持续时间为54秒.
- 平组 (B组) 的平均发作持续时间为42秒.
- 埃托米达导致明显更长的发作持续时间 (p=0.001) 与蒂奥顿相比.
结论:
- 埃托米达在患有严重抑郁症的患者中表现为MECT的诱导剂,表现优越.
- 与埃托米达相关的更长的发作持续时间表明发作质量有所改善.
- 进一步的研究可能会探索埃托米达在优化MECT协议中的作用.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.5K
10:54Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
214
相关概念视频
Electroconvulsive Therapy
771
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
771
Parenteral Anesthetics: Overview
540
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
